F2RL1 and breast carcinoma: In addition, Dr. Ruf and his team developed PAR2 mutant mice, including PAR2-deficient (PAR2−/−) models, to study PAR2’s specific roles in breast cancer progression, angiogenesis, diet-induced obesity and related metabolic disorders.